Table 2

Univariate analysis and multivariate analysis of overall survival

VariableUnivariate analysisMultivariate analysis
β95%CIPβ95%CIP
Age (years) < 500.0031.003 (0.714–1.409)0.085
Gender (N), male: female0.1311.140 (0.710–1.829)0.589
AFP (μg/L), < 400: ≥ 400−0.1950.823 (0.589–1.150)0.254
ALT (U/L), < 40: ≥ 40−0.0250.976 (0.674–1.413)0.897
Total bilirubin (μmol/L) > 3000.9052.472 (1.461–4.183)0.0010.732.075 (1.210–3.559)0.008
Hbs Ag (N), positive: negative0.0791.082 (0.681–1.721)0.738
HBV-DNA (copies/mL) < 1,0000.1241.122 (0.764–1.680)0.536
Tumor number, single0.0551.056 (0.740–1.508)0.764
Tumor diameter, < 5 cm−0.0390.962 (0.686–1.348)0.821
Coexistence of PVTT0.3781.460 (0.983–2.167)0.061
Child-Pugh A:B0.4341.543 (1.106–2.154)0.0110.0661.068 (0.700–1.631)0.759
ALP < 135 U/L0.2151.240 (0.870–1.766)0.234
GGT < 45 U/L1.283.596 (0.887–14.576)0.073
PT < 13 S0.2071.230 (0.857–1.766)0.261
BDTT, Intrahepatic: extrahepatic0.5551.743 (1.207–2.516)0.0030.471.600 (1.097–2.332)0.015
Anatomic: local resection0.321.377 (0.989–1.918)0.058